Danaher Corporation
DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterizatioā¦ read more
Healthcare
Diagnostics & Research
47 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$195.07
Price-0.56%
-$1.10
1Y
Price
Market Cap
$137.134b
Large
Price/Earnings 3y Avg5y Avg
24.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+25.1%
EBITDA Margin+17.3%
Net Profit Margin+18.2%
Free Cash Flow Margin+25.1%
EBITDA Margin+17.3%
Net Profit Margin+18.2%
Free Cash Flow MarginRevenue
$25.107b
+0.9%
1y CAGR+1.2%
3y CAGR-1.7%
5y CAGREarnings
$4.004b
+2.1%
1y CAGR-7.8%
3y CAGR-14.3%
5y CAGREPS
$5.63
+2.6%
1y CAGR-6.4%
3y CAGR-13.3%
5y CAGRBook Value
$52.592b
$92.367b
Assets$39.786b
Liabilities$26.558b
DebtDebt to Assets
28.7%
2.8x
Debt to EBITDAFree Cash Flow
$5.466b
+0.6%
1y CAGR-2.8%
3y CAGR-7.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company